← Evidence map

ReviewCurrent oncology (Toronto, Ont.)2015

Management of egfr tki-induced dermatologic adverse events.

B Melosky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

26 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

2 trials

NCT04864717phase 498 enrolled2021NCT05204758phase 330 enrolled2016
Full record →Abstract, authors, funding and every citing paper · PMID 25908911